Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaoru Sanjie Capsule for Cyclomastopathy
NCT02929420Phase 4Unknown
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Oct 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of xiaoru sanjie in Fibrocystic breasts (2 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoints: the size of breast lumps at 90 days, the scope of breast lumps at 90 days and 2 more. Status: unknown.
02
Drugs
xiaoru sanjie
03
Conditions
Fibrocystic breasts
Beyond the preview
Go deeper on NCT02929420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02929420.